Page last updated: 2024-08-26

bosentan anhydrous and Apoplexy

bosentan anhydrous has been researched along with Apoplexy in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brockmeyer, DL; Day, RW; Feola, GP	1

Other Studies

1 other study(ies) available for bosentan anhydrous and Apoplexy

Article	Year
Safe treatment of pulmonary hypertension with bosentan in a patient with moyamoya disease and cerebral ischemia. Journal of child neurology, 2010, Volume: 25, Issue:4 Topics: Antihypertensive Agents; Bosentan; Brain; Brain Ischemia; Calcium Channel Blockers; Cerebral Angiography; Cerebral Arteries; Cerebral Revascularization; Cerebrovascular Circulation; Child; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Moyamoya Disease; Receptors, Endothelin; Risk Assessment; Stroke; Sulfonamides; Treatment Outcome	2010

Article

Year

Safe treatment of pulmonary hypertension with bosentan in a patient with moyamoya disease and cerebral ischemia.

Journal of child neurology, 2010, Volume: 25, Issue:4

Topics: Antihypertensive Agents; Bosentan; Brain; Brain Ischemia; Calcium Channel Blockers; Cerebral Angiography; Cerebral Arteries; Cerebral Revascularization; Cerebrovascular Circulation; Child; Endothelin Receptor Antagonists; Female; Humans; Hypertension, Pulmonary; Magnetic Resonance Imaging; Moyamoya Disease; Receptors, Endothelin; Risk Assessment; Stroke; Sulfonamides; Treatment Outcome

2010